🔎 Trials Near Me

Home › Bleeding › California

Pag-aaral pangklinika para sa Bleeding sa California

12 pag-aaral para sa Bleeding ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05958342

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Valley Clinical Trials, Inc, Covina
  • North Coast Cardiology, Encinitas
  • Mission Cardiovascular Research Institute, Fremont
  • at 7 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07175428

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Mission Cardiovascular Research Institute, Fremont
  • National Institute of California Heart and Vein Specialists, Huntington Beach
  • Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07626411

Onyx™ Liquid Embolic IDE Clinical Study

  • University of California, Irvine, Irvine
  • Stanford Medical Center, Palo Alto
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318

Oxytocin Pharmacokinetics and Pharmacodynamics

  • Stanford University, Stanford
Nagre-recruitPhase 2
Edad 18 hanggang 50 · Kababaihan · Na-update Ago 21, 2026 · NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 20 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT04278404

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

  • Torrance Memorial, Torrance
Nagre-recruitPhase 3
1 Month · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06664775

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Stanford
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT04045665

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

  • University of California San Diego, San Diego
  • Planned Parenthood of the Pacific Southwest, San Diego
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Kababaihan · Na-update Hun 15, 2026 · NCT06820177

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update May 27, 2026 · NCT05568719

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.